Feb 24, 2026 05:40AM

Feb 23, 2026 12:32PM

Feb 2, 2026 09:00AM

Jan 20, 2026 06:39AM

Jan 13, 2026 04:52AM

Jan 2, 2026 08:53AM

Dec 31, 2025 01:54PM Baird on Axsome Therapeutics (AXSM): 'Incrementally positive on regulatory updates'

Dec 31, 2025 01:19PM

Dec 31, 2025 12:42PM

Dec 31, 2025 08:25AM

Dec 31, 2025 08:24AM

Dec 31, 2025 06:55AM

Nov 6, 2025 07:01AM

Jul 22, 2025 07:28AM Cantor Fitzgerald Reiterates Overweight Rating on Axsome Therapeutics (AXSM)

Jul 22, 2025 06:38AM

Jul 18, 2025 09:58AM

Jun 10, 2025 09:24AM

Jun 10, 2025 06:39AM

Jun 9, 2025 11:54AM

Jun 9, 2025 07:02AM

Apr 7, 2025 02:31AM Jefferies Starts Axsome Therapeutics (AXSM) at Buy

Apr 4, 2025 07:00AM

Jan 21, 2025 06:41AM

Jan 13, 2025 12:50PM

Nov 26, 2024 07:00AM

Sep 16, 2024 08:43AM

Mar 28, 2024 06:29AM

Mar 26, 2024 07:23AM Axsome Therapeutics (AXSM) PT Raised to $127 at Citi

Mar 25, 2024 06:31AM

Mar 19, 2024 03:34AM

Jan 4, 2024 07:04AM

Nov 1, 2022 05:34AM

Apr 19, 2022 09:24AM

Jun 15, 2021 07:01AM

Sep 21, 2020 07:04AM Axsome Therapeutics (AXSM) Reports Expedited Development of AXS-12 for Treatment of Narcolepsy Based on FDA Breakthrough Therapy Meeting

Aug 5, 2020 07:18AM

Jan 13, 2020 06:05AM

Dec 17, 2019 09:19AM

Dec 3, 2019 09:16AM

Dec 3, 2019 06:05AM

Oct 21, 2019 07:02AM

Oct 2, 2019 08:47AM Axsome Therapeutics (AXSM) to Provide Update on Continued Progress at Cantor Global Healthcare Conference

Jan 30, 2019 07:00AM

Dec 27, 2018 07:01AM

Oct 17, 2018 09:37AM

Oct 17, 2018 07:02AM

Oct 16, 2018 07:03AM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All